926 related articles for article (PubMed ID: 23205541)
1. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
[TBL] [Abstract][Full Text] [Related]
3. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
Boissy RE; Visscher M; DeLong MA
Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
[TBL] [Abstract][Full Text] [Related]
5. Anti-Pigmentation Effects of Eight
Ahn HY; Choo YM; Cho YS
J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a depigmenting gel serum comprising tranexamic acid, niacinamide, 4-butylresorcinol, phytic acid, and a mixture of hydroxy acids that targets the biological processes regulating skin melanogenesis.
Furmanczyk M; Brown A; Bustos J; de Henestrosa ARF; Trullas C; Granger C; Jourdan E
J Cosmet Dermatol; 2024 Jun; 23(6):2058-2065. PubMed ID: 38549196
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
[TBL] [Abstract][Full Text] [Related]
9. Topical treatment of hyperpigmentation disorders.
Rendon M; Horwitz S
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
[TBL] [Abstract][Full Text] [Related]
10. Hypopigmentary effects of 4-n-butylresorcinol and resveratrol in combination.
Kim SY; Park KC; Kwon SB; Kim DS
Pharmazie; 2012 Jun; 67(6):542-6. PubMed ID: 22822544
[TBL] [Abstract][Full Text] [Related]
11. 4-n-butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells.
Lee SJ; Son YH; Lee KB; Lee JH; Kim HJ; Jeong EM; Park SC; Kim IG
Int J Cosmet Sci; 2017 Jun; 39(3):248-255. PubMed ID: 27666581
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
Won YK; Loy CJ; Randhawa M; Southall MD
Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
[TBL] [Abstract][Full Text] [Related]
13. The unravelling of the complex pattern of tyrosinase inhibition.
Deri B; Kanteev M; Goldfeder M; Lecina D; Guallar V; Adir N; Fishman A
Sci Rep; 2016 Oct; 6():34993. PubMed ID: 27725765
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
[TBL] [Abstract][Full Text] [Related]
15. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
Maeda K; Fukuda M
J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
[TBL] [Abstract][Full Text] [Related]
16. Effect of the combination of different depigmenting agents in vitro.
Martínez-Gutiérrez A; Asensio JA; Aran B
J Cosmet Sci; 2014; 65(6):365-75. PubMed ID: 25898763
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives.
Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE
Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684
[TBL] [Abstract][Full Text] [Related]
18. Plants from Brazilian Cerrado with potent tyrosinase inhibitory activity.
Souza PM; Elias ST; Simeoni LA; de Paula JE; Gomes SM; Guerra EN; Fonseca YM; Silva EC; Silveira D; Magalhães PO
PLoS One; 2012; 7(11):e48589. PubMed ID: 23173036
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
Kamagaju L; Morandini R; Bizuru E; Nyetera P; Nduwayezu JB; Stévigny C; Ghanem G; Duez P
J Ethnopharmacol; 2013 Apr; 146(3):824-34. PubMed ID: 23439030
[TBL] [Abstract][Full Text] [Related]
20. Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises.
Zolghadri S; Beygi M; Mohammad TF; Alijanianzadeh M; Pillaiyar T; Garcia-Molina P; Garcia-Canovas F; Munoz-Munoz J; Saboury AA
Biochem Pharmacol; 2023 Jun; 212():115574. PubMed ID: 37127249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
